top of page

Kevin Meyer

Kevin Meyer

Business Development at Neurimmune

Pharma & Biotech

Kevin Meyer is a Senior Business Development Manager at Neurimmune, a Swiss clinical-stage biopharmaceutical company developing next-generation antibody therapeutics for protein aggregation diseases. He has more than 11 years of experience spanning neuroscience, antibody drug discovery, and business development. At Neurimmune, he has held roles of increasing responsibility, transitioning from scientific project and team leadership into business development. He also served as Business Development Manager at AL-S Pharma, supporting the development of AP-101 for amyotrophic lateral sclerosis. Kevin Meyer holds a PhD in Neuroscience completed within the ZNZ International PhD Program in Neuroscience of ETH Zurich and the University of Zurich.

bottom of page